"This award recognizes Prescient's efforts to reduce heart attack deaths using our Shield, the first product specifically designed to treat soft, vulnerable plaques," said Patricia Scheller, CEO, Prescient Medical, Inc "We believe the Shield will change the treatment paradigm from repairing damage after a patient has had a heart attack to preventing plaque rupture and avoiding the attack altogether. For a privately funded, early-stage company to receive this award is extraordinary, given that previous recipients include Boston Scientific and Bristol-Myers Squibb."
Existing technologies for coronary artery disease focus on hard plaque that narrows the artery. Balloon angioplasty and traditional stents use high pressure to "crack" open hard plaque and scaffold the artery to improve diameter and restore blood flow.
Prescient's vProtect(TM) Luminal Shield is low-force and self-expanding, which creates less arterial injury, promotes healthy cell coverage and stabilizes vulnerable plaque, the cause of up to 85% of heart attack deaths.
"This unique device supports the body's natural healing process and promotes growth of endothelial cells over a vulnerable plaque lesion's thin fibrous cap to prevent it from rupturing," explained Bhavatharini Rajesh, Research Analyst, Frost & Sullivan.
Rajesh added, "The vProtect(TM) Luminal Shield should revolutionize treatment of vulnerable plaque, the leading cause of heart attack. Essentially, this technology allows interventional cardiologists to prevent a heart attack before it happens."
About Prescient Medical, Inc.
Prescient Medical, Inc. is a privately held medical device company dedicated to reducing deaths from heart attacks, the leading cause of death in much of the world. For more information, visit www.prescientmedical.com.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. To join our Growth Partnership, please visit http://www.frost.com.
|SOURCE Prescient Medical, Inc.|
Copyright©2009 PR Newswire.
All rights reserved